Merck picks circular path to RNA and commits $250M to biotech startup Orna
Merck aims to bolster its genetic medicines pipeline through a new research alliance with Orna Therapeutics, a startup whose technology forms RNA into a circle […]
cancer
Intelerad Acquires PenRad Technologies
What You Should Know: – Today, Intelerad, a leading global provider of enterprise medical imaging solutions, announced its acquisition of PenRad, a software provider for […]
Philips Appoints New CEO Amid Respiratory Device Recall
Philips CEO Roy Jakobs What You Should Know: – Philips today announced that Roy Jakobs is proposed to succeed Frans van Houten as President and Chief […]
How Actionable Data and Expert Analysis Supports Service Providers, Fosters Better Care and Ensures Financial Benefits
Ashish Kachru, CEO at DataLink Approximately 42% of Medicare beneficiaries are enrolled in Medicare Advantage plans—a segment projected to reach 46% by 2025. Due to […]
For Medically Vulnerable Families, Inflation’s Squeeze Is Inescapable
ROSAMOND, Calif. — Deborah Lewis rose from bed before dawn and signed in to her phone so she could begin delivering fast food, coffee, and […]
AstraZeneca & Daiichi drug wins another FDA approval, this time in lung cancer
On the heels of receiving a landmark FDA approval in breast cancer, AstraZeneca and Daiichi Sankyo drug Enhertu won an additional approval in non-small cell […]
UnitedHealthcare Awards $11M in Grants to Address Social Determinants of Health
What You Should Know: – Health insurer UnitedHealthcare has donated $11M in grants to nonprofit organizations across 11 states. – These grants are part of […]
Avenda Health Receives FDA Exemption for AI-Enabled Prostate Cancer Therapy
What You Should Know: – Avenda Health, an AI healthcare company creating the future of prostate cancer care, has received FDA Investigational Device Exemption (IDE) for its FocalPoint […]
Viome Life Sciences launches at-home oral/throat cancer test for consumers
The saliva-based test has been found to have 95% specificity and 90% sensitivity. Consumers can purchase it online and have it shipped to their house.
Samples of Popular Diabetes Drug Contain Potential Carcinogen, F.D.A. Says
Testing found nitrosamine contamination in some samples of Januvia, but regulators will allow Merck to continue selling the drug for now.
BMS reports data that could give its cell therapy an edge over rival J&J product
Bristol Myers Squibb has data showing that its multiple myeloma treatment Abecma beat the standard of care, preliminary Phase 3 results that could support moving […]
After ‘a Lot of Doors Shut in Our Face,’ Crusading Couple Celebrate Passage of Burn Pit Bill
The battle was just beginning for Le Roy Torres and his wife, Rosie, when the Army captain returned to Texas in 2008, already starting to […]
GSK pays $100M to partner on a cancer drug with new twist on immunotherapy
GSK is partnering with Mersana Therapeutics on the development of an antibody-drug conjugate that is approaching Phase 1 testing. Unlike other ADCs that deliver a […]
What is the Potential for Digital Twins in Healthcare?
David Talby, CTO, John Snow Labs Digital twins are virtual representations of an object or system that spans its lifecycle, is updated from real-time data, […]
Stanford Medicine Taps Komodo Health Platform to Study COVID-19 Ripple Effects
What You Should Know: – Today, Komodo Health announced that its platform will be used in studies led by Stanford Medicine focused on the short- […]
Tribun Health, Mindpeak Partner on AI Diagnostic Tool for Breast Cancer for Pathologists
What You Should Know: – Tribun Health, the European leader in software development for digital pathology, is pleased to announce a strategic partnership with Mindpeak, […]
Annexus Health Raises $33M to Optimize Patient Access and Affordability
What You Should Know: – Annexus Health, Inc. has announced its Series B financing of $33 million, which was led by leading digital health growth […]
Samsung EVP Outlines Vision for Digital Health and Wellness
TaeJong Jay Yang, EVP and Head of Health R&D for Samsung What You Should Know: – This week, TaeJong Jay Yang, EVP and Head of […]
AmeriHealth New Jersey, Thyme Care partner to help members through cancer journey
In the collaboration, AmeriHealth New Jersey will educate its members on the Thyme Care model so they know to access it if they have a […]
Ipsen’s latest R&D alliance brings novel T cell-activating drugs for cancer
Ipsen has been an active dealmaker lately, and it just struck another one that takes the pharmaceutical company into a new area of drug research. […]
Aiming to bring drug combos into earlier lines of cancer therapy, IDRx lands $122M
Taking inspiration from the success of drug cocktails that halt viral infections, startup IDRx aims to develop cancer drug combinations that stop tumor escape. The […]
FDA hits pause on Beam Therapeutics’ off-the-shelf cell therapy for blood cancers
Beam Therapeutics’ application to begin human testing of a cell therapy made with base-editing technology is now under an FDA clinical hold. In other clinical […]
Aloe Is Put to the Test Against Cancer
From a case report to a randomized controlled trial, aloe is put to the test against cancer. For a half century, aloe vera “gel processors […]
After Roe, Pregnant Women With Cancer Diagnoses May Face Wrenching Choices
Urgent questions arise about how care of pregnant women with cancer will change in states where women are unable to terminate pregnancies
Biopharma has a brand new target: Cancer-specific collagen
Researchers at the University of Texas MD Anderson Cancer Center published a new study revealing that cancer cells make their own unique form of collagen […]
UK scientists say they have found cancer driver in junk DNA
It has suspected for many years that some diseases may be linked to non-coding or ‘junk’ DNA, but the mechanism behind the pathology hasn’t been […]
Aloe Fails to Help Radiation Therapy Skin Burns
What are the effects of aloe on radiation burns caused by cancer treatment and on the cancer itself? “Worldwide attention was drawn to the possible […]
What is the Enhancing Oncology Model (EOM)?
The Oncology Care Model (OCM) is dead. The Oncology Care Model was a voluntary, alternative payment model (APM), that “included financial and performance accountability for […]
Harvard spinout lands $40M to bring in vivo drug discovery to cancer
Technological advances are moving drug discovery work to computers, but experimental medicines still must be tested in animals. Startup Manifold Bio is developing technology that […]
FDA delay means BeiGene, Novartis must wait longer for cancer drug decision
The FDA has deferred a regulatory decision on an esophageal cancer drug from partners BeiGene and Novartis, citing the need to complete inspections of the […]
How Effective Is Chemotherapy for Colon, Lung, Breast, and Prostate Cancers?
How effective is chemotherapy for colon, lung, breast, and prostate cancers? “Over the last several decades…medicine has waged a major war against cancer, concentrating on […]
$3.7 Trillion Reasons to Centralize Chronic Disease Management
Ty Vachon M.D., Cofounder at Oatmeal Health 59% of all Americans (194 million) suffer from at least one chronic disease, and almost one in three adults […]
What to Know About Gene Therapy
Gene therapy is making a world where cancer and AIDS can be cured, and a person can alter their genetic makeup, changing the direction of […]
Herbicide chemical linked to cancer found in majority of urine samples in CDC study
A new Centers for Disease Control and Prevention (CDC) study revealed a common herbicide chemical linked to cancer was detected in the majority of urine […]
In America, Cancer Patients Endure Debt on Top of Disease
RAPID CITY, S.D. ― Jeni Rae Peters would make promises to herself as she lay awake nights after being diagnosed with breast cancer two years […]
RefleXion Medical Raises $125M for Biology-Guided Radiotherapy
What You Should Know: – RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) for all stages of cancer, today announced […]
Estimating quality of life in oncology
How do you measure changes in quality of life for patients with cancer? Today we will review 3 different approaches: health state based, health state […]
Amgen joins Kernal Bio’s $25M financing as the startup brings mRNA 2.0 to cancer
Kernal Biologics has technology that enables the delivery of messenger RNA therapies to a wider range of destinations in the body. The Series A financing […]
COTA Appoints Noel Alaka as VP of Life Sciences
Noel Alaka, VP of Life Sciences at COTA What You Should Know: Today, oncology real-world data analytics company COTA announced the appointment of Noel Alaka as Vice President of […]
How to Choose the Right Oncologist in Mumbai
Oncologists are Cancer Specialty Doctors that are trained in the treatment and diagnosing of cancer in patients. Cancer is the leading killer of most patients […]
Cancer Drug Greatly Reduces Deaths in Hospitalized Covid Patients
A new study found that sabizabulin reduced the risk of death by 55 percent, but some experts were cautious about overinterpreting the results.
Cancer Drug Greatly Reduces Deaths in Hospitalized Covid Patients
A new study found that sabizabulin reduced the risk of death by 55 percent, but some experts were cautious about overinterpreting the results.
AstraZeneca broadens its scope in blood cancers with $100M TeneoTwo buyout
AstraZeneca is acquiring TeneoTwo in a $100 million bet on that biotech’s lymphoma drug candidate, which is designed to go after two targets. It’s the […]
Chicago ARC Launches Health Equity Innovation Venture Collaborative
What You Should Know: – The Chicago ARC, a new venture collaborative focused on accelerating health equity solutions, has signed Memorandums of Understanding (MOUs) with […]
Stevia and Monk Fruit vs. Aspartame and Splenda
The natural plant-based sweeteners stevia and monk fruit (Luo Han Guo) are pitted head-to-head against aspartame and Splenda. A number of artificial sweeteners have been […]
Precision Medicine: Is Personalized Care Really Here?
What You Should Know: – New Definitive Healthcare report, Is Personalized Care Really Here? analyzes the US claims data to review how precision medicine has […]
Certified Organic Meat Put to the Test
Researchers tested 76 samples of different kinds of organic and conventional meats for 33 different carcinogens. A study on carcinogenic risk associated with the intake […]
BMS cancer drug’s expanded approval gives it an edge over a Gilead cell therapy
The new FDA approval for Breyanzi moves the Bristol Myers Squibb cancer cell therapy into an earlier line of treatment for an aggressive type of […]
Ipsen’s $247M Epizyme acquisition brings approved cancer drug & more in pipeline
Ipsen is paying $247 million to acquire Epizyme, a cancer drug developer with one FDA-approved product: follicular lymphoma therapy Tazverik. The drug is a modest […]
Biopharma firm Radius Health is going private in an $890M M&A deal
Two private equity firms have reached an $890 million deal to buy Radius Health, a company whose main asset is the commercialized osteoporosis drug Tymlos. […]
How to Reduce the Cancer-Causing Properties of Meat
What are the preparation methods to reduce exposure to carcinogens in cooked meat? What are some ways we can decrease our exposure to the carcinogenic […]
100 Million People in America Are Saddled With Health Care Debt
Elizabeth Woodruff drained her retirement account and took on three jobs after she and her husband were sued for nearly $10,000 by the New York […]
2nd NSCLC Drug Development Summit
The 2nd NSCLC Drug Development Summit returns for its second year to unite biopharma and academic leaders during an exciting era of personalized medicine. The industry is uniting to address […]
ImCheck fetches €96M for antibodies that activate immune cells against cancer
ImCheck Therapeutics aims to broaden the reach of cancer immunotherapy with antibody drugs that activate a rare but powerful type of immune cell called gamma […]
Tessa Therapeutics takes in $126M for cell therapies, and more biotech financings
Ten biotech companies were able to raise more than $500 million in combined financing in the past week. Here’s a recap of the funding activity, […]
Key takeaways from ASCO’s annual meeting
Last weekend, health care professionals, patients, scientists and biopharmaceutical researchers gathered for the American Society of Clinical Oncology’s (ASCO) annual meeting. With over 200 sessions […]
4 Steps for Operationalizing the FDA’s Call To Improve Health Outcomes for All Patients
C.K. Wang, Chief Medical Officer of COTA, Inc. In April, FDA Commissioner Dr. Robert Califf laid out areas of challenge and opportunity when it comes […]
GSK immunotherapy shows promise as alternative to surgery in certain rectal cancers
A small Memorial Sloan Kettering Cancer Center study found that all rectal cancer patients treated with GSK drug Jemperli showed a complete response at six […]
Roche bispecific drug Lunsumio lands European nod in follicular lymphoma
Follicular lymphoma patients in Europe now have a new treatment option. The European Commission approved Roche drug Lunsomio, a bispecific antibody designed to go after […]
Philips’ Future Health Index 2022 Report: 4 Key Trends to Know
What You Should Know: – Today, Philips announced the publication of its Future Health Index (FHI) 2022 report: ‘Healthcare hits reset: Priorities shift as healthcare leaders navigate a […]
PMV’s ASCO data show signs of drugging ‘undruggable’ p53 protein across tumor types
PMV Pharmaceuticals has its first clinical data showing that its lead therapeutic candidate can hit p53, a tumor-suppressing protein long thought to be undruggable. After […]
She’s 31, Has Stage 4 Kidney Cancer — And Talked Openly About It in a Job Interview
Katie Coleman stood face-to-face with a choice no job seeker should ever have to make. She could tell her prospective employer she had stage 4 […]
Scaling-Up Inclusive Healthcare Initiatives in Low- and Middle-Income Countries
Non-communicable diseases (NCDs) are on the rise in low- and middle-income countries (LMICs), increasing the financial and health burden affecting these vulnerable populations. To reverse […]
BMS bets $4.1B on lung cancer drug that could best products from Pfizer, Roche
Bristol Myers Squibb is splashing out $4.1 billion to acquire Turning Point Therapeutics, a clinical-stage biotech whose lead drug is currently in pivotal testing as […]
Regeneron is paying $900M for full rights to cancer drug partnered with Sanofi
Regeneron Pharmaceuticals has big plans for cancer immunotherapy Libtayo and it believes it can better execute on them if it has full control of the […]
Repare relinquishes cancer drug to Roche, gets $125M to finance growing pipeline
Roche’s deep oncology pipeline is adding a drug candidate from Repare Therapeutics that works by interfering with a DNA repair mechanism of cancer cells. Repare […]
Outdated Pain Models & The Rise of New Science on Chronic Pain
Yoni Ashar, Ph.D., Clinical Advisor at Lin Health More than 50 million adults in the United States – more than 20% – suffer from chronic […]
St. Peter’s Health to Deploy Innovaccer Health Cloud for Optimized Care Management
What You Should Know: St. Peter’s Health, a regional nonprofit healthcare system in Helena, Montana, is moving to the InnovaccerⓇ Health Cloud’s Data Activation Platform […]
After Marijuana Legalization Did Opioid Overdoses Go Up, Stay the Same, or Go Down?
What happened in states after medical marijuana laws were passed? Did opioid overdoses go up, stay the same, or go down? Millions of people in […]
ASCO 2022 ahead: Clinical trial updates and data readouts to watch for
The American Society of Clinical Oncology’s annual meeting begins this week, including the presentation of more than 2,800 abstracts. Amgen, Roche, and Sierra Oncology are […]
4th RAS-Targeted Drug Development Summit
For decades, RAS has existed as an elusive therapeutic target, and drugging this high-value oncogene was deemed impossible. Despite this, the first-ever FDA-approved KRAS G12C inhibitor has […]
Black Salve Is a Dangerous Scam
Is black salve, a paste made from bloodroot, safe and effective for the treatment of skin cancer? “Despite warnings from the American Academy of Dermatology […]
Cancer Mortality Among Black Individuals in the US
Cancer is the 2nd leading cause of death in the US, just behind heart failure. Yet in recent years, we have seen that improved prevention, […]
Buried Under Dirt or Under Debt: Can Patients Survive the Struggle of Getting Care?
Srulik Dvorsky, TailorMed CEO and Founder New patients at a cancer center in Michigan receive a 79-page handbook when their treatments commence. The handbook includes […]
ICYMI: First pediatric patient to receive CAR-T cell therapy celebrates 10 years of being cancer-free
Recently, NBC News’ Today did a profile on one of the first pediatric patients in the world to receive a CAR-T cell therapy for the […]
Reproducibility, Trust, and the Digital Laboratory
Kevin Vigilante MD, MPH EVP, Chief Medical Officer at Booz Allen Hamilton George Plopper, Sr. Lead Technologist at Booz Allen Hamilton Over the last decade, […]
CAR T without the toxicity: Kelonia gets $50M for a new take on cell therapy
Kelonia Therapeutics is developing cell therapies made by the in vivo engineering of a patient’s cells made possible by the targeted delivery of a genetic […]
FDA sounds caution on Foghorn cancer drug with a partial hold after patient death
The lead cancer drug candidate of Foghorn Therapeutics is now under a partial clinical hold following a patient death. According to the biotech, the patient […]
Targeted Radiopharmaceuticals Summit US (TRP US)
The inaugural Targeted Radiopharmaceuticals Summit US will bring together a worldwide community of specialists to address long-standing challenges in radiopharmaceutical development at all stages, from bench to […]
Cerner Collaboration to Increase Access to Cancer Clinical Trials
What You Should Know: – Cerner, Elligo Health Research® and Freenome are collaborating to enable a clinical trial through the Learning Health Network to help advance early cancer detection. – Together they […]
Flagship merges two of its biotechs to form cellular microenvironment-focused Sonata
Sonata Therapeutics is developing drugs that reprogram cellular microenvironments to send signals intended to have curative effects. Cancer is the initial focus of the biotech, […]
Report: More than 500 medicines in development to treat disorders of the blood
Today, PhRMA released a new report covering 549 medicines in development to potentially treat disorders of the blood, including blood cancers. These conditions pose a […]
To focus on cancer, Chimerix sells rights to antiviral drug that defined the biotech
Chimerix is selling global rights to smallpox drug Tembexa, the biotech’s only FDA-approved product, as a way to fund clinical development of a therapy in […]
BMS builds on BridgeBio alliance, inking deal for rights to KRAS cancer drug
Bristol Myer Squibb is getting rights to BBP-398, a contender in the chase for drugs that address difficult-to-target KRAS mutations. Meanwhile, BridgeBio Pharma receives some […]
OncoHost Raises $35M for AI-Powered Precision Oncology Platform
What You Should Know: – OncoHost, an AI-powered precision oncology platform, today announced a $35M Series C funding round led by ALIVE Israel HealthTech VC, […]
Regulatory recap: J&J vaccine limits, full Enhertu approval, a Vertex hold & more
The FDA amended emergency authorization of Johnson & Johnson’s Covid-19 vaccine. In other regulatory news this past week, drug approvals include a cancer drug that […]
An Apple a Day May Keep the Pharmacist Away
Which would save more lives: eating an apple a day or taking statin drugs? Does an apple a day really keep the doctor away? That’s […]
Kelonia Therapeutics Emerges with $50M to Deliver Precision Targeted Genetic Medicines
What You Should Know: – Kelonia Therapeutics, a Boston-based biotech company focused on vivo gene delivery, launched with a $50 million in Series A funding […]
INVEST Pitch Perfect winner: Athelo helps patients navigate cancer journey
Athelo Health’s software is a personal coach that supports women with breast and gynecological cancers. The startup was judged co-winner in the pharmatech category during […]
3 Steps to Approach & Tackle Digital Transformation in Healthcare
Michael Norring, President and CEO of GCSIT Artificial intelligence (AI) is predicted to save the US healthcare economy $150 billion by 2026. Replacing legacy systems […]
Oxidized Cholesterol and Alzheimer’s Disease
Oxidized cholesterol can be a hundred times more toxic than regular cholesterol, raising additional concerns about foods such as ghee, canned tuna, processed meat, and […]
Nkarta’s natural killers flash potential as next-gen cell therapies for cancer
Two natural killer (NK)cell therapy candidates from Nkarta now have preliminary Phase 1 clinical data suggesting these therapies are helping patients in two types of […]
Roche breast cancer drug fails in Phase 2 following similar stumble by rival Sanofi
Experimental Roche drug giredestrant failed to meet the main goal of a Phase 2 study in advanced breast cancer. The disappointing results allow competitors to […]
TCR-based Therapeutics for Solid Tumors Summit
Are you using TCRs to target solid tumors yet? With Immunocore having achieved commercialization for the first TCR therapy in both the US and EU […]
Mayo Clinic Partners with VUNO to Develop AI-Driven Precision Oncology Solutions
What You Should Know: – Mayo Clinic has signed a research agreement with VUNO, a global medical artificial intelligence (AI) company to develop advanced AI-driven […]
Using NLP Technology To Uncover Real-World Patient Insights
It’s estimated that humans create a combined 2.5 quintillion bytes of data each day – and that around 90% of all data to ever exist was created […]
Regeneron captures new piece for cancer with $250M Checkmate Pharma buyout
Regeneron Pharmaceuticals is paying $250 million cash to acquire Checkmate Pharmaceuticals, a clinical-stage biotech developing drugs that activate the innate immune system. The biotech’s lead […]
Transcarent Launches Oncology Care for Collaborative Cancer Care Experience
What You Should Know: – Transcarent, a new, different, and better health and care experience company for employees of self-insured employers and their families launches […]
BMS and Nektar end cancer drug alliance after two more clinical trial failures
Bristol Myers Squibb and Nektar Therapeutics are ending a cancer drug research alliance after data showed the combination of their respective drugs failed clinical trials […]
GlaxoSmithKline expands its cancer scope with $1.9B Sierra Oncology acquisition
GlaxoSmithKline is further building out its cancer drug portfolio by acquiring Sierra Oncology, a biotech whose FDA-ready myelofibrosis drug has clinical data showing advantages over […]
Viagra-Type Drugs and Melanoma Skin Cancer
What is the role of erectile dysfunction drugs like Cialis and Levitra in the promotion and progression of prostate cancer and melanoma? Of the half-dozen […]
PathAI and GlaxoSmithKline Partner to Accelerate Research and Drug Development
What You Should Know: – PathAI and GSK announced a multi-year strategic artificial intelligence (AI) partnership today with a focus on accelerating research and- building drug development programs […]
Werewolf cancer drug strikes right note with Jazz Pharma, sparking licensing deal
Jazz Pharmaceuticals is licensing rights to a Werewolf Therapeutics cytokine therapy that’s on track to reach clinical testing next year. The deal gives Jazz a […]
Novartis cancer drug is now first approved therapy for group of rare, genetic diseases
A Novartis drug that stops abnormal cell growth in breast cancer now has an additional FDA approval treating a group of rare disorders characterized by […]
Potential of Implementing Polygenic Risk Scores in Healthcare Systems
Dr. George Busby, co-founder and Chief Scientific Officer at Allelica The promise of personalized medicine is a world in which interventions, screening, and therapeutics are […]
Blueberries Can Improve Artery Function
What is the optimum dose of wild blueberries to eat at a meal? A single serving of blueberries can help mediate the arterial dysfunction induced […]
FDA places partial hold on Curis cancer drug after patient death in clinical trial
The FDA placed a partial hold on a Curis drug in development for treating leukemia after a patient treated in a clinical trial died. The […]
Novartis restructures to save $1B; pharma & oncology to merge into single unit
Novartis unveiled a corporate restructuring that is consolidating some operations in cash-saving moves expected to lead to $1 billion in annual savings. The shakeup means […]
Digital Health Disconnect Creates Unnecessary Roadblock to Patient Engagement
Aaron Kaufman, EVP at Carenet Health By all accounts, the last two years have accelerated consumer adoption of digital tools for managing nearly every aspect of our […]
Data and regulatory roundup: Pfizer’s feat, an ADHD miss, Eli Lilly’s CRL & more
A pharmaceutical giant reported a Phase 3 success for a potential blockbuster drug, while four other companies reported disappointing data from their respective clinical trials. […]
COTA Promotes Miruna Sasu to President and CEO
Miruna Sasu, Ph.D., MBA, President & CEO at COTA, Inc. What You Should Know: – COTA, Inc., an oncology real-world data and analytics company, announced […]
Celsius Therapeutics heats up with $83M and an IBD drug on path to the clinic
Single-cell analysis biotech Celsius Therapeutics has raised $83 million to advance its pipeline of drugs for autoimmune disorders and cancer. The startup’s lead autoimmune program, […]
Why Mainstream Precision Medicine Hinges on Healthcare HPC Storage
Adam Marko, Director of Life Science Solutions at Panasas The healthcare industry is experiencing a data deluge, and it shows no sign of slowing down. […]
Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risk
The move follows recalls of other medications found to have higher levels of potential carcinogens.
Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risk
The move follows recalls of other medications found to have higher levels of potential carcinogens.
Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risk
The move follows recalls of other medications found to have higher levels of potential carcinogens.
Cell therapy biotech Affini-T gets $175M; KRAS is lead genomic cancer target
Affini-T Therapeutics is developing new cell therapies for cancer that could overcome limitations of the first generation of cell therapies. The initial genomic cancer targets […]
Tempus Launches Pathology-Driven AI Platform
What You Should Know: – Tempus, a provider of artificial intelligence and precision medicine, today announced the launch of Edge, an innovative platform that allows pathologists […]
BMS nabs FDA nod for first drug in new class of cancer immunotherapies
Bristol Myers Squibb’s Opdualag has been approved by the FDA, a first for a drug that goes after a new cancer target called LAG-3. The […]
Canopy Launches Out of Stealth with $13M for Intelligent Care Platform for Oncology
What You Should Know: – Today, Canopy announced it is launching out of stealth with $13 million in funding to work with leading oncology practices […]
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient […]
Sanofi and Seagen team up to grow a new crop of ADC cancer drugs
Antibody drug conjugates have made scientific and regulatory progress in recent years. Sanofi is partnering with ADC specialist Seagen in a multi-drug alliance that keeps […]
House Rx Secures $30M to Optimize the Specialty Pharmacy Experience for Patients and Their Care Teams
What You Should Know: – Today House Rx, a health technology platform that empowers oncology and rheumatology physician practices with medically integrated dispensing, announced they’ve secured […]
Nektar drug key to muti-billion dollar BMS deal fails pivotal test in melanoma
Bristol Myers Squibb bet more than $1.8 billion that Nektar Therapeutics’ drug could be combined with the pharma giant’s Opdivo to expand the reach of […]
Modest activity, tolerability issues sink lead Harpoon cancer drug prospect
Harpoon Therapeutics is discontinuing work on its lead drug in prostate cancer following disappointing data in an early-stage clinical trial. Though Harpoon has other drugs […]
MorphoSys cuts R&D from Constellation deal to focus on clinical-stage cancer drugs
MorphoSys is cutting the drug discovery and R&D work of Constellation Pharmaceuticals, a company it acquired lats year in a $1.7 billion deal. This consolidation […]
Scenic Biotech scores $31M to take aim at genetic modifiers for cancer & rare disease
Targeting mutations isn’t the only way to treat genetically driven diseases. Scenic Biotech is developing molecules to target genes that suppress disease, and it has […]
MediView XR Secures $9.9M for Augmented Reality Surgical Navigation Platform
What You Should Know: – MediView XR, Inc., raises $9.9M in SAFE financing syndicated by Inside View Investments, LLC, a private investment firm. MediView has raised approximately […]
To Engage and Activate Patients, CRM Alone Isn’t Enough
Michael Linnert, Founder and CEO of Actium Health We talk about patient engagement a lot in healthcare today. But the reality is, we often don’t […]
Why The End of the Public Health Emergency is Everyone’s Problem
Heather Korbulic, Senior Policy and Strategy Lead, GetInsured The COVID-19 pandemic led to sweeping healthcare policy changes that enable vulnerable Americans to receive affordable health coverage and access […]
Alpine Immune Sciences cancer drug trial placed on partial hold after patient death
The FDA placed a partial clinical hold on a Phase 1 study testing experimental Alpine Immune Sciences cancer drug davoceticept in combination with Merck cancer […]
FDA regulatory roundup: two approvals, three rejections & one clinical hold
The FDA approved drugs from Johnson & Johnson and CTI BioPharma in the past week. Complete response letters were issued to Gilead Sciences, Amryt, and […]
Black Female Co-founders CancerIQ Raises $14M to Improve Cancer Early Detection and Prevention
CancerIQ Co-Founders Feyi Olopade Ayodele & Olufunmilayo (Funmi) Olopade, MD What You Should Know: – CancerIQ, a Chicago-based platform powering early cancer detection and prevention across broad […]
Massachusetts General Hospital to Co-Develop VR Digital Therapeutic for Stem Cell Patients
What You Should Know: – Massachusetts General Hospital (“MGH”) announced a research agreement with Rocket VR Health, an emerging digital therapeutics company developing clinically validated […]
XRHealth Secures $10M to Expand Virtual Reality Treatment in the Metaverse
What You Should Know: – XRHealth, the gateway to the healthcare metaverse, announced today that they raised $10M in funding to expand virtual healthcare treatment in the Metaverse. The […]
Crisis in the U.S. Healthcare Workforce: Why It’s Time to introduce AI
Andrew Pucher, CEO of Dascena, Inc. One of the many acute challenges during the pandemic has been the departure of approximately 18% of the U.S. […]
Benchling Acquires Overwatch Research to Accelerate Breakthroughs for Biopharma Companies
What You Should Know: – Today, R&D Cloud pioneer Benchling announced it has acquired Overwatch Research to accelerate in vivo research. – The acquisition will […]
4 things to know about biopharmaceutical efforts to fight cancer
A recent study published in Nature is a profound reminder of how far we’ve come in the fight against cancer. Authors of the study, which […]
Mayo Clinic Tests Shark Cartilage Supplements for Cancer
Shark cartilage supplements carry risks, but so do many cancer treatments. The question is, do they work? When it comes to marketing unproven cancer treatments, […]
Why The Future of Healthcare Interfaces is Fluid
Sajjad Kamal, Healthtech Partner at Global Ventures Nazmus Saquib, HCI & Interfaces Expert Tools we use to do our daily work have rapidly evolved following […]
Medtronic, AWS to Provide Underserved Communities with AI-Assisted Colon Cancer Screening
Genius Intelligent Endoscopy Module What You Should Know: – Medtronic and AWS, today announced a partnership to provide underserved communities with artificial intelligence (AI)-assisted colonoscopy […]
Connecting the Dots – Building Data Bridges for a Better Healthcare Future
Jen Goldsmith, President Tendo Systems Healthcare data is increasing at an exponential rate. Approximately one-third of the world’s data volume is being generated by the […]
Helping Clinical Trial Sites Improve Study Recruitment and Retention
Tzvia Bader, CEO and co-founder, TrialJectory The clinical trial industry is, once again, at an uncertain crossroads. And while it might be assumed that the […]
J&J partners with startup Remix, aiming to treat disease by “tuning” RNA
Several biotech companies are rising to the challenge of developing small molecules to drug RNA. Remix Therapeutics is joining the chase, but its different approach […]
Medicaid Coverage of Family Planning Benefits: Findings from a 2021 State Survey
This report presents survey findings from 41 states and DC about coverage policies for fee-for-service Medicaid in place as of July 1, 2021, for the […]
Do Cell Phones Affect Cognitive Function?
The World Health Organization concluded that cell phone radiation may cause brain tumors, but what about effects on cognitive function? “At present, we do not […]
Roivant Sciences launches Hemavant to chase BMS in anemia from blood disease
An Eisai drug that produced disappointing data in a myelodysplastic syndrome study is getting another shot under a newly launched Roivant Sciences subsidiary, Hemavant. Roivant […]
Cancer biotech Indapta nabs $50M for new approach to natural killer cell therapy
Natural killers cells are the focus of a growing number of companies pursuing next-generation cell therapies for cancer. Indapta Therapeutics focuses on a subset of […]
C2i Genomics, Twist Bioscience Partner to Develop Whole-Genome Cancer Reference Materials
What You Should Know: – Today, Twist Bioscience and cancer genomics startup C2i Genomics announced a partnership to develop whole-genome cancer reference materials. – This […]
Endeavor Bio adds $101M to test ex-Eli Lilly, Roche drug in cancer & lung fibrosis
Endeavor BioMedicines aims to kill two birds with one stone—that stone being a small molecule drug. Taladegib targets a cell signaling pathway associated with both […]
Johnson & Johnson faces push to force global ban on talc baby powder sales
Move to hold shareholder vote follows withdrawal of product in US and Canada and lawsuits alleging link to cancer cases The healthcare company Johnson & […]
Softbank leads Dewpoint’s $150M round as multiple programs march toward clinic
Dewpoint is developing drugs targeting biomolecular condensates, tiny droplets in cells that contain proteins and nucleic acids. Dysfunction of these organelles can play a role […]
Racial Disparities in Cancer Outcomes, Screening, and Treatment
This brief provides an overview of recent data on cancer incidence and mortality, risk factors, screening, treatment, and outcomes by race and ethnicity. Racial disparities […]
Are Provoked Urine Challenge Tests for Heavy Metals a Scam?
Is testing for body burden of heavy metals like mercury with “urine mobilization tests,” “challenge tests,” and “provoked urine tests” just a scam? Environmental risk […]
Jasper Health Raises $25M for Cancer Care Navigation and Experience Platform
What You Should Know: – Jasper Health, an NYC-based cancer care coordination and experience platform raise $25M in Series A funding led by General Catalyst. – The round, […]
New Cancer Care Navigator Thyme Care Starts Out with $22M Series A & Big Name Backing
By JESSICA DaMASSA, WTF HEALTH Thyme Care is a cancer navigation platform that is looking to use technology to make the kind of high-touch care […]
Foresite and GV pour $40M into startup’s move to CHIP into new disease biology
TenSixteen Bio has emerged from stealth aiming to develop drugs for diseases caused by genetic mutations accumulated as we age. The startup has been incubating […]
Do Any Benefits of Alcohol Outweigh the Risks?
What would happen if you effectively randomized people at birth to drink more or less alcohol their whole lives? Would they get more or less […]
Gilead Sciences cancer drug hit with partial hold due to adverse event concern
Gilead Sciences did not disclose details about the safety concern that led to an FDA partial clinical hold on five studies evaluating its cancer drug, […]
Sierra succeeds where Gilead missed; FDA filing now planned for blood cancer drug
Sierra Oncology myelofibrosis drug momelotinib achieved the main and secondary goals of a pivotal test and the biotech now plans to seek FDA approval. Sierra […]
Is It Better to Drink a Little Alcohol Than None at All?
Even if alcohol causes cancer and there is no “French paradox,” what about the famous J-shaped curve, where excessive drinking is bad, but light drinkers […]
Kura Oncology leukemia clinical trial to resume after FDA lifts partial hold
The FDA placed the partial hold on the study last November following a patient death suspected to be linked to a known complication of leukemia […]
Biliary tract cancer drug granted orphan drug designation in US
The US regulator has granted biliary tract cancer therapy Silmitasertib orphan drug designation. There are currently no treatments for this rare cancer, and the US […]
Syapse, Pfizer Extends Collaboration to Generate Real-World Evidence in Breast Cancer
What You Should Know: – Syapse, a real-world evidence company that informs cancer care, announced that it will extend its collaboration with Pfizer to generate […]
New data show continued decline in death rates for cancer patients related to treatment advances
According to a new report from American Cancer Society (ACS), death rates for cancer patients in the United States continue to decrease. Each year, ACS […]
ImmPACT Bio reels in $111M to prevent tumor escape with novel cell therapies
Despite the targeted approach of some cancer treatments, tumors can find ways to escape, leading patients to relapse. ImmPACT Bio will apply its Series B […]
Feb. 3 Web Event: Understanding and Addressing Racial Disparities in Cancer Outcomes, Care, and Treatment
The COVID-19 pandemic has raised awareness and sharpened the discussion of systemic racial disparities in the U.S. health care system. These inequities existed long before […]
Sugemalimab plus chemo boosts lung cancer survival, trial reveals
Lung cancer drug sugemalimab has delivered positive results following a phase 3 trial. EQRx’s GEMSTONE-302 study evaluated the efficacy and safety of the investigational anti-PD-L1 […]
The Best Source of Resveratrol
Is there any benefit to resveratrol? If so, should we get it from wine, grapes, peanuts, or supplements? “Alcohol is a neurotoxin which can cause […]
Clinical trial begins of lung cancer immunotherapeutic
Cancer Research UK’s Centre for Drug Development, working with the Ludwig Institute for Cancer Research and Vaccitech, has begun a phase I/IIa clinical trial of […]
Scotland backs AstraZeneca drug as first-line treatment for NSCLC
Scotland has approved AstraZeneca’s Tagrisso (osimertinib) as a monotherapy for the for the first-line treatment of adult patients with locally advanced or metastatic non-small cell […]
AstraZeneca bets $75M on Scorpion’s precision approach to tough cancer targets
AstraZeneca’s partnership with Scorpion Therapeutics will focus on transcription factors that are known to play a role in cancer but have been difficult to target […]
Can Alcohol Cause Cancer?
If even light drinking can cause cancer, why don’t doctors warn their patients about it? As I discuss in my video Can Alcohol Cause Cancer?, […]
Long-Excluded Uterine Cancer Patients Are Step Closer to 9/11 Benefits
Tammy Kaminski can still recall the taste of benzene, a carcinogenic byproduct of burning jet fuel. For nine months after the 9/11 attacks, she volunteered […]
BeyondSpring is laying off 35% of staff in wake of FDA rejection of lead drug
BeyondSpring Pharmaceuticals’ corporate reorganization comes about six weeks after the FDA rejected the biotech’s drug for a complication experienced by cancer patients. The company still […]
Apple Peels Put to the Test for Chronic Joint Pain
Are the health benefits associated with apple consumption simply due to other healthy behaviors among apple-eaters? Regular apple intake is associated with all sorts of […]
Startup Avenge Bio nabs $45M for novel cell therapy approach to ovarian cancer
The field of biotechs pursuing new interleukin-2 cancer immunotherapies is filled with companies engineering different versions of that signaling protein. Avenge Bio CEO Mike Heffernan […]
Sanofi bets big on AI again, paying $100M to start drug R&D pact with Exscientia
Sanofi’s new alliance with artificial intelligence biotech Exscientia spans up to 15 small molecule drugs in cancer and immunology. If drugs from the partnership reach […]
Putting patient perspectives at the heart of kidney cancer research
Kidney cancer is the 14th most common cancer, with approximately 400,000 new cases worldwide every year. Renal cell carcinoma (RCC) is by far the most […]
Ambagon adds $85M for molecular glues that stick to elusive protein targets
Biotech startup Ambagon Therapeutics is taking a new approach to making elusive protein targets “druggable” by using molecular glues. The biotech has a pipeline of […]
Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy
That is the title of my recent paper in Advances in Therapy along with co-authors Christian Jackisch, Federico Manevy, Suzanne Frank, and Nicki Roberts. This […]
The War on Cancer at 50: The Origin Story Begins With a Socialite Citizen-Lobbyist
The roots of the National Cancer Act can be traced to a small home in Watertown, Wisconsin. In the early 1900s, a girl named Mary […]
Cancer therapies lead way as FDA tallies 60 drug approvals in 2021
As in previous years, cancer products topped the list of new FDA-approved therapies in 2021. But the list of drug approvals is notable for other […]
Sanofi’s $1B Amunix acquisition aims for targeted, safer T cell engagers for cancer
In acquiring Amunix, Sanofi becomes the latest big pharmaceutical company to strike a deal to gain access to technology that improves the safety and efficacy […]
Novartis, BeiGene ink another deal; plan for tests of checkpoint cancer drug combos
Novartis is partnering with BeiGene on the development of a drug that addresses TIGIT, a hot cancer immunotherapy target. The Swiss pharma giant is committing […]
BMS joins off the shelf cell therapy chase with alliance on Immatics cancer drug
Bristol Myers Squibb is paying $150 million up front for global rights to an Immatics biologic drug designed to recruit a patient’s T cells to […]
How to Balance the Risks and Benefits of Mammograms
Fact boxes can quantify benefits and harms in a clear and accessible format. When it comes to cancer screening, doctors “have too often ignored” the […]
As genetic testing expands, evidence and awareness needed to spur adoption
Genetic tests are becoming available for a wider range of applications. During a CB Insights panel discussion, Phil Febbo of Illumina and Alicia Zhou of […]
Doctors Tested for Basic Understanding of Mammogram Math
If doctors don’t understand health statistics, how can they possibly properly counsel patients? “In these mammography wars, rational thinking can be easily lost.” Mammograms are […]
KFF’s Kaiser Health News Wins NABJ Award for Excellence in Radio Journalism for a Story About Teaching Children to Cope with the Constant Threat of Gun Violence in Their Communities
The National Association of Black Journalists has recognized KFF’s Kaiser Health News and two of its editorial partners with a 2021 “Salute to Excellence” award […]
Oncology Doctors Say the Build Back Better Act Will Slash Cancer Care Funding — A Skewed Argument
“An independent analysis shows that payments for cancer care will be slashed by close to 45% causing cancer clinics to close and massively raising your […]
Cancer & immunology biotech Odyssey embarks with $218M, Gary Glick at helm
Odyssey Therapeutics is the latest startup formed by serial biotech entrepreneur Gary Glick. Odyssey’s destination is oncology and immunology drugs that address novel disease targets, […]
Breast Cancer Can Grow and Spread for Decades Before “Early” Detection
“Early” detection is actually really late. Without mammograms, breast cancer may not be caught for an average of 22.8 years. With mammograms, though, breast cancer […]
Early clinical data validate rare immune cell for Adicet’s off-the-shelf cancer therapy
Adicet Bio makes its therapies from gamma delta T cells, a rare type of immune cell that the company believes offer advantages compared to other […]
Learn More Than 97% of Doctors About Lead-Time Bias
After reading this, you’ll know more than an estimated 97 percent of doctors about a critical concept called lead-time bias. While running for president of […]
FDA turns down BeyondSpring chemo complication drug, asks for another trial
BeyondSpring Pharmaceuticals said the FDA wants another clinical trial to demonstrate patient benefit for its drug, a small molecule developed to treat a dangerous and […]
Curie Therapeutics unveils $75M to widen scope of radiopharmaceuticals for cancer
Radiopharmaceuticals deploy radiation to damage cancer DNA, but Curie Therapeutics sees these therapies opening the door to a wider range of ways to kill tumors. […]
Patient death prompts clinical trial pause for Kura Oncology leukemia drug
The FDA placed a partial clinical hold on a Kura Oncology leukemia drug following the death of one patient in the early-stage study. Kura executives […]
It Takes a Team: A Doctor With Terminal Cancer Relies on a Close-Knit Group in Her Final Days
The decisions have been gut-wrenching. Should she try another round of chemotherapy, even though she barely tolerated the last one? Should she continue eating, although […]
FDA hands out approvals to Takeda transplant drug, Aadi Bio cancer therapy
Takeda Pharmaceutical won FDA approval for Livtencity, an antiviral developed to treat cytomegalovirus infection in transplant patients. The agency also approved an Aadi Biosciences drug, […]
Does Cell Phone Radiation Affect Fertility?
What is the effect of cell phone radiation on sperm motility and DNA damage? “Are men talking their reproductive health away?” There have been “unexplained […]
Did the Oncology Care Model produce cost savings?
The answer is ‘yes’, but the magnitude of these savings are relatively small and more than offset by additional OCM program costs. Keating et al. […]
Overtreatment of Ductal Carcinoma In Situ
Nine out of ten women don’t realize that some breast cancers would never have caused any problems or even become known in one’s lifetime. This […]
FDA approves PharmaEssentia interferon drug for a rare type of blood cancer
Polycythemia vera, a rare blood cancer characterized by the overproduction of red blood cells, now has its first FDA-approved drug treatment. The agency awarded the […]
Oncorus Signs an Exclusive License Agreement with Gaeta for IL-12 in Combination with Immune Checkpoint Inhibitors to Treat Cancer
Shots: Gaeta to receive $0.2M up front and is eligible to receive ~$7.5M in clinical and regulatory milestones based on product and indication The agreement […]
Notable Labs Launches by Acquiring Rights to Volasertib – Will Use Data, AI to Fast-Track Cancer Treatment
Thomas Bock, M.D., Chief Executive Officer of Notable What You Should Know: – Coming out of stealth, Notable Labs, a pioneer and developer of predictive precision medicines, […]
Millions of Years of Healthy Life Lost Due to Cannabis
Every year, cannabis is estimated to result in two million years of healthy life lost due to disability. How much is that compared with alcohol […]
Biotech startup Marengo unveils $80M and a new way to get T cells to fight cancer
Apple Tree Partners’ latest cancer biotech company, Marengo Therapeutics, is using antibodies to selectively activate T cells to fight cancer. Led by former Merck KGaA […]
Biologics manufacturing drives Evotec’s $435M U.S. stock market debut
Evotec is an old player in the life sciences, but in offering new shares on the Nasdaq, the Germany-based company plans to bolster its new […]
Those Who Claim the Greatest Benefit From Mammograms May Ironically Suffer the Most Harm
The mammogram paradox is that women who are harmed the most, are the ones who claim the greatest benefit. While false-positive results, pain during the […]
Shoreline Biosciences secures $140M for off-the-shelf NK cell therapies for cancer
Gilead Sciences and BeiGene, which started research alliances with Shoreline Biosciences earlier this year, are among the investors in the biotech’s latest financing. The preclinical-stage […]
How Much Cancer Do Mammograms Cause?
What is the risk-benefit ratio of the cancers picked up by mammograms and the cancers caused by mammograms? Over the last few decades, our radiation […]
Using bispecific antibodies to advance cancer immunotherapy
Dr Laura Moriarty, senior marketing manager at Bio-Rad, looks at the impressive immuno-therapeutic potential of bispecific antibodies (bsAbs). Bispecific antibodies (bsAbs) are designed to recognise […]
Innovent Entered into a Collaboration Agreement with NeoCura to Evaluate Sintilimab + NEO_PLIN2101 for Cancer in China
Shots: The companies collaborated to evaluate the safety, PK, PD & preliminary efficacy of the combination therapy of Innovent’s sintilimab + NeoCura’s NEO_PLIN2101 in patients […]
Do Mammograms Have to Be Painful?
Excessive breast compression during mammography may not improve image quality and can cause unnecessary pain. False-positive results have been described as “the most frequent harm” […]
Xilio, Ventyx IPOs raise $269M to fuel plans to compete with big pharma drugs
Cancer drug developer Xilio Therapeutics and Ventyx Biosciences, a company with drug candidates in cancer and autoimmune diseases, are the latest life science companies to […]
Already allied with Takeda, Egle raises €40M for its ‘starving’ immunotherapy
In less than two years, Egle Therapeutics launched, partnered with Takeda Pharmaceutical, and found its first cancer targets. Now the startup has €40M in Series […]
Hackensack Meridian Health deploys Google Chrome OS devices, uses Cloud AI for screenings
The New Jersey-based health system initially partnered with Google in 2019. It has now migrated to Google Workspace, providing thousands of Chrome OS devices to […]
Most Women May Experience at Least One False-Positive Mammogram
Odds are most women will get at least one false-positive mammogram, but, thankfully, most women who are called back for further testing of a suspicious […]
Tentarix Bio unveils $50M for biologics with multiple functions, multiple targets
Biotech startup Tentarix Biotherapeutics has come out of stealth with $50 million and technology that develops biologic drugs endowed with multiple functions. The company aims […]
How Is It Possible That Mammograms Don’t Actually Save Lives?
For every life saved by mammography, as many as two to ten women are overdiagnosed and unnecessarily turned into breast cancer patients with all of […]
Untapped Opportunities for Oncology Medical Affairs Striving for better access and more equitable cancer care in communities nationwide
Pharmaceutical companies’ traditional medical education model relies on prominent researchers and publishers in the oncology space, otherwise known as Key Opinion Leaders (KOLs), to spread […]
Next Generation CAR-TCR Summit
The cell therapy field is showing no signs of slowing down, with huge investment and excitement around next generation products and their clinical validation in solid tumour […]
Why Doctors Should Not Encourage Breast Self-Exams
Various health organizations offer clashing mammogram recommendations that range from annual mammograms starting at age 40 to eliminating routine mammograms altogether. Who can you trust? […]
Exo Therapeutics adds $78M as cancer, inflammation drugs march toward clinic
Biotech startup Exo Therapeutics aims to overcome the challenges of drugging proteins by targeting exosites, locations that modulate enzyme activity. The company has four small […]
Anji Pharma adds $70M for clinical trials, expansion of ‘hub and spoke’ biz model
Cross-border biotech Anji Pharma closed $70 million in Series B funding to advance a drug pipeline that includes metabolic and cancer drugs. The biotech’s business […]
Why Are Mammogram Guidelines Conflicting?
When women are fully informed about the risks and benefits of mammograms, 70 percent may choose not to get screened. You may be in that 30 […]
England’s cancer therapy backlog ‘could take more than a decade to shift’
A new report has suggested it could take until 2033 to clear the backlog of cancer treatment in England caused by the pandemic. The analysis […]
Seagen, Genmab antibody drug conjugate gets FDA approval in cervical cancer
The Seagen and Genmab antibody drug conjugate (ADC), named Tivdak, is approved to treat cases of cervical cancer that have returned or spread following treatment […]
90% of Women Appear Misinformed About Mammograms
Most women are just being told what to do, rather than being given the facts needed to make a fully informed decision. “Selling cancer screening can be […]
Covid-Overwhelmed Hospitals Postpone Cancer Care and Other Treatment
It’s a bad time to get sick in Oregon. That’s the message from some doctors, as hospitals fill up with covid-19 patients and other medical […]
Takeda therapy gets speedy FDA nod for lung cancers with rare genetic signature
Takeda Pharmaceutical drug mobocertinib was approved by the FDA to treat non-small cell lung cancer in patients whose tumors carry a rare genetic signature. With […]
Lead Contamination in Calcium Supplements
Do calcium citrate and calcium carbonate have as much lead as calcium supplements derived from dolomite and animal bone? You may remember I’ve explored the role calcium […]
The Effects of Nutritional Yeast for Cancer
How can the beta glucan fiber in brewer’s, baker’s, and nutritional yeast improve wound healing and, potentially, anti-cancer immunity? My video Benefits of Nutritional Yeast for Cancer opens with […]
‘Luckiest Man Alive’: Why 9/11 First Responders’ Outlooks May Improve Even as Physical Health Fails
Ray Pfeifer and Luis Alvarez’s names are on the federal 9/11 legislation that establishes benefits for first responders. Both men fought to make Congress pass […]
Cedars-Sinai Cancer Launches ‘Molecular Twin’ Initiative for Precision Cancer Treatment
What You Should Know: – Cedars-Sinai Cancer and Tempus, a provider of artificial intelligence and precision medicine, are harnessing the power of big data and […]
Roche bets $300M on Adaptimmune tech for off-the-shelf cell therapies for cancer
Roche is partnering with Adaptimmune Therapeutics to develop allogeneic cell therapies based on Adaptimmune’s technology. In addition to these “off-the-shelf” products, the partners will also […]
Startup Modulus embraces AI to design better NK cell therapies for cancer
Modulus Therapeutics recently emerged from stealth with technology from various disciplines and seed funding that the startup is using to develop better cell therapies. Natural […]
Targeting COVID-19 and cancer with immunotherapy advancements
Anna Biosciences’ Dr Anthony Rullo discusses the drug development company’s immunotherapy platform. Over the last 30 years, we have seen dramatic improvements in patient outcomes […]
Takeda’s Pevonedistat Fails to Meet Primary Endpoints in P-III PANTHER Trial as 1L Treatment for Patients with Rare Bone Marrow Cancer
Shots: The P-III PANTHER trial evaluates pevonedistat + azacitidine vs azacitidine alone in patients with higher-risk MDS, CMML and AML The study did not achieve […]
How pharma can help the post-COVID recovery of European cancer care
The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and the changes physicians implemented during the acute […]
Asher Bio’s encouraging early data against rival cancer drug sparks $108M financing
Five months after raising $55 million to back a new technology and a promising lead cancer immunotherapy, Asher Biotherapeutics has reeled in $108 million more. […]
Recognizing National Immunization Awareness Month
Vaccines have played a critical role in reducing the spread of, and in some cases, eliminating the threat of many devastating infectious diseases. They are […]
MedStar Health, MercyOne, Moffitt Cancer Center, Others Double Down on Digital Transformation
What You Should Know: – AVIA, the nation’s leading healthcare innovation network, today announced that the following six new health system Members joined the AVIA Network to accelerate their digital strategies and advance digital capabilities: Lee […]
Ontada, Merck Partner to Facilitate Real World Evidence Studies for Cancer Care
What You Should Know: – Ontada, McKesson’s oncology and insights business, announced a strategic agreement with Merck, known as MSD outside the United States and […]
A biotech startup’s hunt for elusive disease targets scores $60M for drug R&D
Atavistik Bio is one of several companies discovering and developing drugs that work by allostery, binding to less obvious sites of a target protein. Acting […]
Jasper Health Integrates BioIntelliSense’s RPM and COVID-19 Screening Solution for Members
What You Should Know: – Today, BioIntelliSense announced it has formed a strategic collaboration with Jasper Health, an emerging leader of digital engagement for people […]
Foundation Medicine Integrates with Epic EMR for Genomic Insights for Precision Cancer Care
What You Should Know: – Foundation Medicine (FMI) announced today a partnership to integrate its comprehensive genomic testing services into Epic’s electronic medical record (EMR) […]
ADC Therapeutics strikes a $325M royalty deal to fuel its cancer drug strategy
The royalty agreement with HealthCare Royalty Partners will support ADC Therapeutics’ plans to commercialize its newly approved cancer drug and develop the next one in […]
UPMC launches cancer drug discovery company
Called Novasenta, the company is focused on the tumor microenvironment and will leverage its machine-learning platform to pinpoint targets for drug development. It aims to […]
